At a glance
ClinicalIndex Comparison RecordN/ACompleted· 600 enrolled
Drug / intervention
LAL (Light Adjustable Lens) and Light Deliver Device (LDD) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of the Light Adjustable Lens (LAL) in Subjects With Pre-Existing Corneal Astigmatism
In Brief
A clinical study evaluating LAL (Light Adjustable Lens) and Light Deliver Device (LDD) and Monofocal control IOL for Cataract. Completed, enrolled 600 participants across 17 sites.
Detailed Summary
The purpose is to evaluate the Calhoun Vision Light Adjustable Lens (LAL) and Light Delivery Device (LDD) for reducing astigmatism and improving uncorrected vision after implantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedDec 2011
Primary CompletionJun 2016
TodayJul 2026
First PostedDec 21, 2011
Enrollment StartDec 1, 2011
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 14.5 years ago
Interventions
LAL (Light Adjustable Lens) and Light Deliver Device (LDD)device
LAL implanted and adjusted with LDD
Monofocal control IOLdevice
Commercially available monofocal intraocular lens (IOL)